Spiritual sustainability, a hundred years of foundation
Release time:
2020-07-22
Spirit Perpetual, 100 Years of Foundation
Speaker: Peak Health Yerica
Dear Leaders and Colleagues:
Good afternoon!
First of all, I would like to thank the company for giving me such an opportunity to give a speech on this stage. I would like to thank the leaders and colleagues who have always encouraged me, cared about me and helped me grow up. It is you who have given me the courage to stand here.
Before starting the speech, I would like to ask you a few questions. Friends, how many minutes is an hour? What is the passing score of the student's examination paper of 100 ? How many years will it take for two people to get married with each other? Yes, it is 60 ! If you calculate it according to the test results, it may be really bad, but for all the peak people here, this is a proud and proud number. 60 years of wind and rain, 60 years of hard work, 60 years of glorious history, peak people ushered in a new milestone.
Our former chairman once said: "The enterprise spirit of unity and struggle, seeking truth and innovation, determined to take the lead, and climbing the peak forever" is the advantage of our peak.
Innovation is the soul of a nation's progress, an inexhaustible driving force for the development of a country, and an important factor for the prosperity and dominance of an enterprise. In 2007 , Jianfeng Group and China State Construction Group formed an alliance to make full use of the advantages of both parties to jointly seize the market and resources, and put forward the development strategy of "cooperative innovation to strengthen the main business, standardize science and seek development". Strengthen the cement industry, further optimize the pharmaceutical industry, and open up broader prospects. In 2012 , Jianfeng Health Technology Co., Ltd. was officially established. I am honored to join this ranks and have the opportunity to get in touch with Jianfeng Grape Seed Extract and Bone Tai Capsule and promote their products. In this process, I not only understand the company's products, and deeply realize the attitude of an enterprise to the products and the responsibility to the public, that is, to bring good products to the market, so that more people in need can eat assured and effective health care products. I think this is a great human project. I hope to apply what I have learned to my work to help more people who need help and are predestined.
# The foundation of 410000 industry depends on people. If the product is nutrition and the enterprise is the brain, then the personnel is blood. The three complement each other and work together to maintain brain health. High speed operation. Jianfeng is cultivating more talents. Everyone is talented and everyone makes the best use of their talents. This is the talent view of Jianfeng Group.
As a new employee, I have no way to participate in the past, but I believe that under the spirit of sticking to the spirit of unity and struggle, seeking truth and innovation, aspiring to take the top and climbing the top forever, I will witness the scorching posture and splendor of the top again and again. This is how the peak has gone through 20 , 40 , 60 , and will go on so firmly, 80 , 100 , or even longer. This is the mission of our spikes.
San Mao said, I don't want to be profound, I just want to be simple. In the years to come, I will try my best to become a qualified peak person!
My speech is over, thank you!
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page